(NEW YORK) -- New boosters for 5- to 11-year-olds are just weeks away from authorization, the vaccine chief at the Food and Drug Administration, Dr. Peter Marks, said Tuesday. While primary vaccines are already authorized for children 6 months and older, the FDA has yet... Read More.
(NEW YORK) -- Novavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults that can be used on top of the its primary vaccine series or to mix and match... Read More.
(NEW YORK) -- The vaccine company Moderna on Thursday announced it submitted its request for the Food and Drug Administration to authorize its vaccine for children ages 6 months to 6 years, marking a hopeful development in the long journey for parents who are... Read More.
(NEW YORK) -- Two years into the coronavirus pandemic, children under age 6 may be one step closer to being eligible to get vaccinated against COVID-19. Moderna said Wednesday it plans to seek emergency use authorization from the U.S. Food and Drug Administration for its... Read More.
(NEW YORK) -- Moderna said it plans to seek emergency use authorization from the U.S. Food and Drug Administration for its COVID-19 vaccine in children under age 6. The company released clinical trial data Wednesday showing neutralizing antibody levels were similar to those seen in... Read More.
(NEW YORK) -- COVID-19 vaccines for kids under 5 have not yet been authorized, but the U.S.' rollout plan is already in the works. The federal government is prepping an initial 10 million doses of the under-5 Pfizer formula, which will be ready to go... Read More.
(WASHINGTON) -- Nearly two years into the coronavirus pandemic, children ages 5 and under are one step closer to being eligible to be vaccinated against COVID-19. Pfizer on Tuesday asked the U.S. Food and Drug Administration for emergency use authorization of its COVID-19 vaccine for... Read More.
(WASHINGTON) -- Pfizer asked the Food and Drug Administration on Tuesday for emergency use authorization for its vaccine for children under the age of 5. The move puts the process in motion for the FDA to review the data, bring it before its independent advisers... Read More.
(NEW YORK) -- For many parents of unvaccinated toddlers in the U.S., a return to normalcy amid the COVID-19 pandemic seems out of reach. Many have been forced to take time off work or change their schedules to provide care for their children due to... Read More.
(WASHINGTON) -- Pfizer on Tuesday requested the Food and Drug Administration allow all Americans over 18 to be eligible for booster shots, submitting data from a 10,000-person trial that found its third shots to be safe and effective for adults of all ages. The request... Read More.
(WASHINGTON) -- Vaccines for 28 million American children are on the way to authorization after an advisory panel at the Food and Drug Administration voted in support of the Pfizer vaccine for kids ages 5-11 on Tuesday afternoon. The vote was the first step in... Read More.
(WASHINGTON) -- An advisory panel at the Food and Drug Administration will vote Tuesday on whether to move forward with authorizing vaccines for children ages 5-11. The vote will be the first step in a regulatory process for the two-shot Pfizer vaccine for kids. If... Read More.